Skip to main content

Tarsus Pharmaceuticals, Inc S-3ASR, filed Oct 13, 2026

Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals, Inc. registered up to 2,908,692 shares of common stock for resale by selling stockholders; it will receive no proceeds from their sales. AI summary

S-3ASR 2026-10-13
View Original
Added on October 16, 2026